Hologic is an American medical technology company that is recognized for M&A, Product Launches and Research and Development in the 2022 Medical Device Network Excellence Awards.

Hologic has lately been focusing on launching new surgical devices, particularly in the field of women’s health. It has recently expanded its signature gynaecological surgical offering, Omni suite, to include a versatile Omni 30° hysteroscope, the Omni Lok cervical seal and the Omni 5 French seal. 

The company has also bolstered its surgical capabilities with the acquisition of instrument manufacturer Bolder Surgical. 

Hologic has also launched its molecular diagnostic system, Novodiag, which is designed for the on-demand testing of infectious diseases and combines real-time polymerase chain reaction (PCR) with microarray capabilities. The company has also expanded its diagnostics solutions portfolio with the launch of its Genius Digital Diagnostics System, which is to be used for cervical cancer screening.

Company Profile

Hologic develops, manufactures, and supplies medical imaging systems, diagnostic products, and surgical products. It offers products that aid the diagnosis of human diseases; breast imaging and related products and accessories; GYN surgical products, including endometrial ablation system and hysteroscopic tissue removal system; and skeletal health products such as dual-energy X-ray bone densitometry systems and mini C-arm imaging products. 

The company offers these solutions for surgeons, hospitals, clinical laboratories, and healthcare providers. Hologic offers its products and services through direct sales and a network of independent distributors and sales representatives. 

The company operates in Europe, the Americas, and Asia-Pacific. Hologic is headquartered in Marlborough, Massachusetts, the US.